-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

803.O3.6 803. Emerging Tools, Techniques and Artificial Intelligence in Hematology: Reading the Blood: Generative and Discriminative AI in Hematology

Symposia: Emerging Tools, Techniques and Artificial Intelligence in Hematology Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, artificial intelligence (AI), Translational Research, Clinical Research, bioinformatics, computational biology, emerging technologies, Technology and Procedures, machine learning, natural language processing
Saturday, December 9, 2023: 9:30 AM-11:00 AM
San Diego Ballroom AB (Marriott Marquis San Diego Marina)
Moderators:
Caroline A. Heckman, PhD, Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki and Alexander Oeser, PhD, University of Leipzig
Disclosures:
Heckman: Amgen: Honoraria; Kronos Bio: Research Funding; Novartis: Research Funding; Oncopeptides: Research Funding; WNTResearch: Research Funding; Zentalis Pharmaceuticals: Research Funding; Autolus: Consultancy.
9:30 AM

Francisco Marchi1, Marieke Landwehr1*, Fernando Sckaff2*, Xueyuan Cao, PhD3,4*, Raul C. Ribeiro, MD5, Jeffrey E. Rubnitz, MD, PhD5,6, Alan S Gamis, MD, MPH7, E. Anders Kolb, MD8, Richard Aplenc, MD, PhD9,10, Stanley Pounds, PhD11*, Todd A. Alonzo, PhD12,13*, Soheil Meshinchi, MD, PhD14 and Jatinder K. Lamba, PhD15,16,17

1Pharmacotherapy and Translational Research, University of Florida, Gainesville, FL
2University of Florida, Gainesville
3Department of Health Promotion and Disease Prevention, University of Tennessee Health Science Center, Memphis, TN
4St. Jude Children's Research Hospital, Memphis, TN
5Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
6St. Jude Children's Hospital, Memphis, TN
7Hematology/Oncology/BMT, Children's Mercy Kansas City, Kansas City, MO
8Leukemia & Lymphoma Society, Bronx, NY
9Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
10Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
11Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
12Univ. of Southern California Keck School of Med., Monrovia, CA
13Children's Oncology Group, Monrovia, CA
14Translational Sciences and Therapeutics, Fred Hutchinson Cancer Research Center, Seattle, WA
15Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, FL
16Umn Center For Allied Health Programs, Gainesville, FL
17UF Health Cancer Center, University of Florida, Gainesville, FL

9:45 AM

Gianluca Asti, MSc1*, Elisabetta Sauta, PhD1*, Nico Curti, PhD2,3*, Gianluca Carlini, PhD2,3*, Lorenzo Dall'Olio, PhD2,3*, Luca Lanino, MD4, Giulia Maggioni, MD1*, Alessia Campagna1*, Marta Ubezio, MD1*, Antonio Russo, MD1*, Gabriele Todisco, MD1*, Cristina Astrid Tentori, MD1*, Pierandrea Morandini, MEng1*, Marilena Bicchieri, PhD1*, Maria Chiara Grondelli, BSc1*, Matteo Zampini, PhD1*, Erica Travaglino, BS1*, Victor Savevski, MEng1*, Nicolas Riccardo Derus, PhD5*, Daniele Dall'Olio, PhD5*, Claudia Sala, PhD5*, Lin-Pierre Zhao, MD6*, Armando Santoro, MD1*, Shahram Kordasti, MD, PhD7, Valeria Santini, MD8, Anne Sophie Kubasch, MD9*, Uwe Platzbecker, MD10, Maria Diez-Campelo, MD, PhD11*, Pierre Fenaux, MD, PhD6, Amer M. Zeidan, MBBS, MHS12, Torsten Haferlach, MD, PhD13, Gastone Castellani, PhD5*, Matteo Giovanni Della Porta, MD1* and Saverio D'Amico, MSc14*

1Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy
2Department of Physics and Astronomy, University of Bologna, Bologna, Italy
3Data Science and Bioinformatics Laboratory, IRCCS Institute of Neurological Sciences of Bologna, Bologna, Italy
4Humanitas Clinical and Research Center, IRCCS, Rozzano, Milano, Italy
5University of Bologna, Bologna, Italy
6Saint Louis hospital APHP, Paris, France
7King's College London, London, United Kingdom
8MDS Unit, DMSC, AOU Careggi, University of Florence, Firenze, Italy
9Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Medical Center Leipzig, Leipzig, Germany
10Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany
11Department of Hematology, Salamanca-IBSAL University Hospital, Salamanca, Spain
12Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT
13MLL Munich Leukemia Laboratory, Munich, Germany
14Humanitas Clinical and Research Center, IRCCS, Rozzano (Milan), Italy, Italy

10:00 AM

Rong Wang1*, Zhongxun Shi1*, Yuan Zhang2,3*, Minghui Duan4*, Min Xiao, MD5*, Suning Chen6*, Jianyao Huang7*, Xiaomei Hu8*, Jinhong Mei9*, Wenyi Shen, MD1*, Yongyue Wei10* and Jianyong Li, MD1

1Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
2School of Computer Science and Engineering, Southeast University, Nanjing, China
3Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China
4Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China
5Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
6National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China
7Affiliated Provincial Hospital, Anhui Medical University, Hefei, China
8Fujian Medical University Union Hospital, Fuzhou, China
9The First Affiliated Hospital of Nanchang University, Nanchang, China
10Center for Public Health and Epidemic Preparedness & Response, Peking University, Beijing, China

10:15 AM

Jing Sun, Mphil, BEng1*, Desmond Choy, PhD2*, Nicolas Sompairac, PhD2*, Shirin Jamshidi, PhD2*, Michele Mishto, PhD1* and Shahram Kordasti, MD, PhD3

1School of Immunology and Microbial Sciences, King's College London, London, United Kingdom
2Comprehensive Cancer Centre, King's College London, London, United Kingdom
3King's College London, London, United Kingdom

10:30 AM

David Medina, PhD1*, Julieta Sepulveda-Yanez, MSc2*, Diego Alvarez-Saravia3*, Roberto Uribe-Paredes4*, Hendrik Veelken, MD, PhD 5 and Marcelo Navarrete, MD6

1Departamento de Ingenieria en Computacion, Universidad de Magallanes, Punta Arenas, Chile
2Facultad de Ciencias de la Salud, Universidad de Magallanes, Punta Arenas, Chile
3Universidad de Magallanes, Punta Arenas, Chile
4Departamento de Ingenieria en Computacion, University of Magallanes, Punta Arenas, CHL
5Hematology, Leiden University Medical Center, Leiden, Netherlands
6Centro Asistencial Docente y de Investigacion, Universidad de Magallanes, Punta Arenas, Chile

10:45 AM

Vikram Dhillon, DO, MBA1,2, Jeff Aguilar, MD, MBA3 and Suresh Kumar Balasubramanian, MD4,5

1Department of Hematology/Oncology, Neal Cancer Center/Houston Methodist Hospital, Detroit, MI
2Department of Oncology, Karmanos Cancer Center/Wayne State University, Detroit, MI
3Wayne State University/Karmanos Cancer Center, DETROIT, MI
4Karmanos Cancer Institute/Department of Oncology, Wayne State University, Detroit, MI
5Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

*signifies non-member of ASH